Search

Your search keyword '"Rinaldi, Daisy"' showing total 180 results

Search Constraints

Start Over You searched for: Author "Rinaldi, Daisy" Remove constraint Author: "Rinaldi, Daisy"
180 results on '"Rinaldi, Daisy"'

Search Results

1. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

2. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression

3. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

4. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

5. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

6. Differential early subcortical involvement in genetic FTD within the GENFI cohort

7. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

9. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

11. Early neurotransmitters changes in prodromal frontotemporal dementia

12. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

13. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

14. Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort

15. Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort

16. Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers

18. Temporal order of clinical and biomarker changes in familial frontotemporal dementia

19. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

20. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

21. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience

22. Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

23. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog

24. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia

27. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

28. Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years

29. Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias

30. Validation of circulating microRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis

31. Corrigendum to “Dissemination in time and space in presymptomatic granulin mutation carriers: A spatial chronnectome study” [Neurobiology of Aging Volume 108, December 2021, Pages 155–167]

33. The CBI-R detects early behavioural impairment in genetic frontotemporal dementia

34. Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis

35. Low cancer prevalence in polyglutamine expansion diseases

36. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

37. Brain Metabolic Changes in the Presymptomatic Stage of Frontotemporal Dementia Associated with GRN Mutations (S2.006)

38. Plasma Neurofilament Trajectories are Markers of Disease Progression and Severity in Genetic Frontotemporal Dementia (S20.004)

40. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

41. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia

42. CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

43. Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort

45. Brain Metabolic Profile in Presymptomatic GRN Carriers Throughout a 5-Year Follow-up.

46. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

48. MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

49. The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort

50. Differential early subcortical involvement in genetic FTD within the GENFI cohort

Catalog

Books, media, physical & digital resources